Aurobindo Pharma reported INR17.53B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Cipla INR 14.03B 4.48B Jun/2026
Divis Laboratories Ltd INR 12.62B 3.28B Jun/2026
Dr.Reddys Laboratories INR 8.6B 2.14B Jun/2026
Hindustan Unilever INR 39.47B 1.06B Jun/2026
Sun Pharmaceuticals INR 44.18B 4.63B Jun/2026
UPL INR 14.5B 21.08B Jun/2026